Real-time MRI-guided percutaneous sclerotherapy treatment of venous low-flow malformations in the head and neck. (June 2018)

• Record Type: Journal Article
• Authors: Partovi, Sasan; Lu, Ziang; Vidal, Lorenna; Nakamoto, Dean A; Buethe, Ji; Coffey, Michael; Patel, Indravadan J
• Is Part Of: Phlebology. Volume 33:Number 5(2018)
• Page Start: 344
• Page End: 352
• Publication Date: 2018-06
• Subjects: Venous malformation -- real-time -- MRI guidance -- percutaneous sclerotherapy -- Ethanolamine Oleate; Veins -- Diseases -- Periodicals; 616.14
• DOI: 10.1177/0268355517710110
• Languages: English
• ISSNs: 0268-3555

Abstract

Purpose: This manuscript describes the technique of real-time MRI-guided sclerotherapy for low-flow venous malformations in the head and neck based on our institutional experience. Materials and methods: Ethanolamine oleate is used as the sclerosant and is mixed with gadolinium for visualization during the procedure. The five procedural steps include: (I) an initial tri-plane T2-weighted sequence to visualize the lesion; (II) a T1 FSE or trueFISP sequence to assess needle placement and advancement within the lesion; (III) a tri-plane T1 FLASH sequence to monitor sclerosant injection; (IV) a T1 FSE or VIBE sequence to assess sclerosant coverage of the malformation before needle removal; (V) a post-procedural tri-plane T1 fat-saturated sequence to confirm sclerosant coverage of the lesion. Periprocedural medications typically include steroids, antibiotic prophylaxis, and non-steroidal anti-inflammatory medication. Patients are typically admitted for overnight observation. Conclusion: Real-time MRI-guided sclerotherapy for low-flow venous malformations in the head and neck is effective and safe.